BRVE analyst estimates

Braveheart Bio (BRVE) analyst ratings, the average price target and its range, and every firm's latest call.

• 1 firms rate BRVE: 1 buy, 0 hold, 0 sell.
• The average price target is $45.25 from None analysts, from $40.00 to $48.00.

Updated 2026-11-11 00:48 UTC